BIOR Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (17 May 2024 @ 16:00):

Stats
Today's Volume	219 984
Average Volume	452 022
Market Cap	26.18M
EPS	$0 ( 2024-05-15 )
Next earnings date	( $-0.450 ) 2024-05-20
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.0900
ATR14	$0.00300 (0.41%)

Insider Trading

Date	Person	Action	Amount	type
2024-02-15	Desparbes Eric	Buy	325 000	Common Stock
2024-02-15	Neumann Clarke	Buy	230 000	Common Stock
2024-02-15	Mohanty Aditya P.	Buy	819 000	Common Stock
2023-12-18	Athyrium Opportunities Iii Co-invest 1 Lp	Buy	10 430 000	11.00% / 13.00% Convertible Senior Secured Notes due 2028
2023-12-18	Athyrium Opportunities Iii Co-invest 1 Lp	Buy	6 953 000	11.00% / 13.00% Convertible Senior Secured Notes due 2028

INSIDER POWER
-13.71
Last 98 transactions
Buy: 136 819 110 \| Sell: 120 286 948

Volume Correlation

Long: -0.09 (neutral)

Short: -1.00 (very strong negative)

Signal:(42.317) Neutral

Biora Therapeutics, Inc. Correlation

10 Most Positive Correlations

10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Biora Therapeutics, Inc. Correlation - Currency/Commodity

0.03
( neutral )

0.09
( neutral )

0.00
( neutral )

0.21
( neutral )

Biora Therapeutics, Inc. Financials

Annual	2023
Revenue:	$4 000.00
Gross Profit:	$-551 000 (-13 775.00 %)
EPS:	$-7.87

FY	2023
Revenue:	$4 000.00
Gross Profit:	$-551 000 (-13 775.00 %)
EPS:	$-7.87

FY	2022
Revenue:	$305 000
Gross Profit:	$-602 000 (-197.38 %)
EPS:	$-6.40

Financial Reports:

No articles found.

Biora Therapeutics, Inc. Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Biora Therapeutics, Inc.

Biora Therapeutics, Inc., a biotechnology company, engages in developing oral biotherapeutics. The company's targeted therapeutics program uses an ingestible smart capsule for targeted delivery of therapeutics in the gastrointestinal (GI) tract to enhance the treatment of inflammatory bowel diseases; and systemic therapeutics program uses an ingestible capsule for needle-free delivery of biotherapeutics directly into the intestinal mucosa for enhanced systemic uptake. It is also developing diagnostics devices to help characterize the GI tract and diagnose GI diseases, such as small intestine bacterial overgrowth through the development of various technologies to diagnose at the site of the disease. The company was formerly known as Progenity, Inc. and changed its name to Biora Therapeutics, Inc. in April 2022 to reflect its focus on its therapeutics pipeline. Biora Therapeutics, Inc. was founded in 2010 and is headquartered in San Diego, California.

Realtime updates for Biora Therapeutics, Inc. [BIOR]

Upcoming Earnings Alert

Biora Therapeutics, Inc. Options Data

Calls

Puts